Direct medical cost of radiation therapy for cancer patients in Taiwan

Henry W. C. Leung, Agnes L. F. Chan^*

Cancer Center, Department of Radiation Oncology, Min-Sheng General Hospital, Taoyuan.
Department of Pharmacy, Min-Sheng General Hospital, Taoyuan.

DOI: 10.4236/health.2013.56131                

Abstract

Background and purpose: The rising cost of health care is of concern worldwide, in particular, for cancer care. The costs of treatment, including chemotherapeutic drugs and radiotherapy, are no exceptions. The purpose of this study is to explore the direct medical cost of radiotherapy and the annual increasing trend of expenditures in Taiwan. Methods: This study utilized data retrieving from the original claim data of the reimbursement of the Health Insurance Research Database (HIRD) derived from Taiwan’s Health Insurance (HI) program. Detailed data on the direct medical cost within the radiotherapy process for beneficences were extracted from inpatient expenditures by admissions (DD) and ambulatory care expenditures by visits (CD) database according to the reimbursed expenditure code of radiotherapy from January 1, 2000 to December 31, 2005. Prescriptions for radiotherapy were retrieved and the direct medical costs for radiotherapy were collected based on the NHI reimbursement price list of 2005. The annual increasing trend of expenditures was also explored according to the perspective of Bureau Health Insurance of Taiwan. Results: The total direct medical costs of radiotherapy for cancer patients were increasing from 2000 to 2005, which were estimated to US $7.80 million, US $8.09 million, US $7.58 million, US $10.7 million, US $12.2 million and US $15.9 million in 2000, 2001, 2002, 2003, 2004 and 2005, respectively. The increased percentage corresponded to the total healthcare expenditures claimed was increased substantially from 0.82% in 2000 to 1.22% in 2005. The total direct medical costs within the radiotherapy process were also increased gradually if identified by different types of radiotherapy and teaching hospital levels. The direct medical costs attribute to radiotherapy, compared to total health care expenditures in Taiwan, were similar to the costs of anticancer drugs for cancer patients annually. Conclusions: The direct medical costs of radiation therapy increased substantially each year. Further cost analysis on radiation therapy is needed in years beyond 2005.

Keywords

Direct Medical Cost; Radiotherapy; Cancer Patient

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Health Care Finance administration Office of Research and Demonstrations (2008) Health care financing review statistical supplement. US Department of Health and Human Services Baltimore.
[2]	Bureau of health insurance in Taiwan (2013) http://www.nhi.gov.tw/webdata/webdata.aspx?menu=6&menu_id=168&WD_ID=168&webdata_id=2305
[3]	Economist Intelligence Unit (2013) Breakaway: The global burden of cancer—Challenges and opportunities. http://www.livestrong.org/pdfs/GlobalEconomicImpact
[4]	Doe, J. (2013) Treatment options for bowel cancer. http://www.bowelcanceraustralia.org/bca/index.php?option=com_content&view=article&id=499&Itemid=657
[5]	Piana R. (2012) Rising costs in radiation oncology linked to medicare coverage billing technicalities and overtreatment drive costs in radiation therapies. The ASCO Post, 3.
[6]	Boughton, B. (2009) Cuts in reimbursement proposed for radiation oncology in the US. The Lancet Oncology, 10, 939.
[7]	Rosenthal, M.B. (1999) Risk sharing in managed behavioral health care. Health Affairs (Millwood), 18, 204-213. doi:10.1377/hlthaff.18.5.204
[8]	SBU (1996) The Swedish council on technology assessment in health care. Radiotherapy for cancer. Volume1. Cost of radiotherapy in Sweden. Acta Oncologica, 35, 57-71. doi:10.3109/02841869609083988
[9]	Greene, D. (1983) The cost of radiotherapy treatments on a linear accelerator. British Journal of Radiology, 56, 189-191. doi:10.1259/0007-1285-56-663-189
[10]	Atherton, L. (1984) The cost of radiotherapy treatments on a linear accelerator. British Journal of Radiology, 57, 106-107. doi:10.1259/0007-1285-57-673-106
[11]	Wodinsky, H.B. and Jenkin, R.D. (1987) The cost of radiation treatment at an Ontario regional cancer centre. CMAJ, 137, 906-909.
[12]	Goddard, M., Maher, E.J., Hutton, J. and Shah, D. (1991) Palliative radiotherapy—Counting the costs of changing practice. Health Policy, 17, 243-256. doi:10.1016/0168-8510(91)90127-J
[13]	Penn, C.R. (1992) Megavoltage irradiation in a district general hospital remote from a main oncology centre: The Torbay experience reviewed. Journal of Clinical Oncology, 4, 108-113. doi:10.1016/S0936-6555(05)80978-1
[14]	Perez, C.A., Kobeissi, B., Smith, B.D., et al. (1993) Cost accounting in radiation oncology: A computer-based model for reimburse-ment. International Journal of Radiation Oncology*Biology*Physics, 25, 895-906. doi:10.1016/0360-3016(93)90321-L
[15]	Smith, R.D., Jan, S. and Shiell, A. (1995) Efficiency considerations in the expansion of radiation therapy services. International Journal of Radiation Oncology*Biology* Physics, 31, 379-385. doi:10.1016/0360-3016(94)00473-X
[16]	Kesteloot, K., Lievens, Y. and van der Schueren, S.E. (2000) Improved management of radiotherapy departments through accurate cost data. Radiotherapy & Oncology, 55, 251-262. doi:10.1016/S0167-8140(99)00034-1
[17]	Dunscombe, P., Roberts, G. and Walker, J. (1999) The cost of radiotherapy as a function of facility size and hours of operation. British Journal of Radiology, 72, 598- 603.
[18]	Lievens, Y., van den Bogaert, W., Kesteloot, K. (2003) Activity-based costing: A practical model for cost calculation in radiotherapy. International Journal of Radiation Oncology*Biology*Physics, 57, 522-535. doi:10.1016/S0360-3016(03)00579-0
[19]	Norlund, A. (2003) Costs of radiotherapy. Acta Oncologica, 42, 411-415. doi:10.1080/02841860310011140
[20]	Glimelius, B., Bergh, J., Brandt, L., et al. (2001) The Swedish council on technology assessment in health care systematic overview of chemotherapy effects in some major tumour types-summary and conclusions. Acta Oncologica, 40, 135-54. doi:10.1080/02841860151116169
[21]	Vogenberg, F.R. (2001) Introduction to applied pharmacoeconomics. The Mcgraw-Hill Companies, Inc., New York.
[22]	Lievens, Y., van den Bogaert, W. and Kesteloot, K. (2003) Activity-based costing: A practical model for cost calculation in radiotherapy. International Journal of Radiation Oncology*Biology*Physics, 57, 522-535. doi:10.1016/S0360-3016(03)00579-0
[23]	Ploquin, N.P. and Dunscombe, P.B. (2008) The cost of radiation therapy. Radiotherapy & Oncology, 86, 217-223. doi:10.1016/j.radonc.2008.01.005
[24]	Kesteloot, K., Lievens, Y. and van der Schueren, E. (2000) Improved management of radiotherapy departments through accurate cost data. Radiotherapy & Oncology, 55, 251- 262. doi:10.1016/S0167-8140(99)00034-1